Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Gains from Sales and Divestitures (2016)

Pro Dex's Gains from Sales and Divestitures history spans 4 years, with the latest figure at $5000.0 for Q2 2016.

  • For Q2 2016, Gains from Sales and Divestitures fell 24.99% year-over-year to $5000.0; the TTM value through Jun 2016 reached $5000.0, down 24.99%, while the annual FY2016 figure was $5000.0, 24.99% down from the prior year.
  • Gains from Sales and Divestitures for Q2 2016 was $5000.0 at Pro Dex, roughly flat from $5000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $9166.0 in Q2 2014 and bottomed at -$9166.0 in Q3 2013.
  • The 4-year median for Gains from Sales and Divestitures is $5000.0 (2015), against an average of $2361.2.
  • The largest annual shift saw Gains from Sales and Divestitures skyrocketed 172.74% in 2014 before it decreased 27.27% in 2015.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at -$9166.0 in 2013, then surged by 172.74% to $6667.0 in 2014, then fell by 25.0% to $5000.0 in 2015, then changed by 0.0% to $5000.0 in 2016.
  • Per Business Quant, the three most recent readings for PDEX's Gains from Sales and Divestitures are $5000.0 (Q2 2016), $5000.0 (Q1 2016), and $5000.0 (Q4 2015).